Space
Update
Space
Want SpaceX exposure. RKLB is the public play. ARKX is a trap.
Quick Snapshot
| Signal | Reading |
|---|---|
| Overall | 🟡 Watch - RKLB news mixed, major contract but test failure |
| Key insight | RKLB just won largest contract ever (18 satellites). ARKX has NO SpaceX. |
Action Matrix
| Action | Stocks | Why |
|---|---|---|
| 🔍 WATCH | RKLB | Mixed signals - big contract but Neutron test failed |
| ❌ DON'T BUY | ARKX | Misleading - has NO SpaceX |
Legend
- RSI
↓= Oversold (<30) - potential buying opportunity - RSI
↑= Overbought (>70) - FOMO warning, may pullback - 52wkHi = % from 52-week high (how far below peak)
Data
| Stock | Price | 1D | 7D | 30D | 3M | 52wkHi | RSI | Status | Action |
|---|---|---|---|---|---|---|---|---|---|
| RKLB | $78.57 | +1% | -14% | +1% | +28% | -21% | 43 | 🟡 Consolidating | 🔍 Watch |
| ARKX | $31.64 | -1% | -6% | +1% | +2% | -11% | 33 | 🟡 Flat | 🔍 Watch |
News Summary
RKLB - Rocket Lab
| Date | Headline | Sentiment |
|---|---|---|
| 2026-02-02 | Largest contract ever - 18 missile-defense satellites | 🟢 Bullish |
| 2026-01-29 | Stock could explode in 2026 - 38% YTD gain | 🟢 Bullish |
| 2026-01-28 | Congress killed Mars sample-return funding | 🔴 Bearish |
| 2026-01-27 | Neutron test failure - stock dropped 20% | 🔴 Bearish |
| 2026-01-30 | Analyst target $72.9 - mixed outlook | 🟡 Neutral |
Net sentiment: Mixed - big contract win offset by test failure
ARKX - ARK Space ETF
- Hit 52-week high
- Renamed to "ARK Space & Defense Innovation ETF"
- Still has NO SpaceX (that's in ARKVX venture fund)
Analysis
RKLB - Rocket Lab
Thesis: Public rocket company. Real SpaceX competitor. Actually builds rockets.
- Price: $74.15
- 30D: -0.6% (consolidating after hitting $100)
- BULLISH: Just won largest contract ever (18 defense satellites)
- BEARISH: Neutron rocket test failed, stock dropped 20%
- Real rockets, real revenue, real volatility
Verdict: 🔍 Watch - mixed signals. Big contract is good, test failure is concerning.
ARKX - ARK Space ETF (AVOID)
Thesis: Space ETF... but has NO SpaceX.
- Price: $31.67
- 30D: +4.1%
- Hit 52-week high
- PROBLEM: Top holdings are Trimble, Kratos, Iridium
- SpaceX is in ARKVX (venture fund, not public)
Verdict: ❌ Don't Buy - not what it seems
ARKVX - ARK Venture Fund (Reference)
Note: This is where SpaceX actually lives. Not publicly traded. Venture fund with minimum investment requirements.
The Gold
Key Discoveries
| Discovery | Implication |
|---|---|
| RKLB won 18-satellite defense contract | Largest deal ever, defense revenue secured |
| RKLB Neutron test failed | Technical risk is real, stock volatile |
| ARKX hit 52-week high | Running on hype, not SpaceX exposure |
| ARKX renamed to "Space & Defense" | Pivoting to defense, less pure space play |
Mistakes
| Mistake | Lesson |
|---|---|
| Assumed ARKX = SpaceX exposure | Always check actual ETF holdings |
Open Questions
- Is RKLB Neutron failure a one-time issue or systemic?
- Is $65-70 good RKLB entry after pullback?
- Will defense contracts offset commercial rocket challenges?
Next Actions
Related
10 eventsNo direct external sources are attached to this read.